Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us dr. J.C. Oosterwijk

Research interests

clinical genetics

familial / hereditary cancer

hereditary breast / ovarian cancer

Publications

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Occurrence of Malignancies Other than Breast and Ovarian Cancer in Female Carriers of a BRCA1/2 Germline Pathogenic Variant

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis

Breast cancer risks associated with missense variants in breast cancer susceptibility genes

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

Genetic control of tumor development in malformation syndromes

Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants

Press/media

Wat als de kans op kanker levensgroot is? 'Ik ga niet zitten wachten tot ik ziek word'

Erfelijke kanker in de familie

Laten testen of je erfelijk belast bent?

Sustainable Development Goals

SDG 3 - Good Health and Well-beingSDG 5 - Gender EqualitySDG 16 - Peace, Justice and Strong Institutions

More information about the Sustainable Development Goals.